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Abstract
Experience has shown that genetically engineered, truncated polyketide synthases 
sometimes gave very low production levels (as low as l-2mg per litre broth culture). To 
understand how the protein producing them works, it is important to be able to characterise 
the metabolites. To do this effectively these small quantities o f product must be isolated 
from the broth so that NMR spectra may be obtained.
Within this thesis is described details o f the initial analysis by GC-MS, the separation and 
subsequent isolation by preparative HPLC-MS and the interpretation o f the NMR spectra. 
Work is also described relating to the pre-HPLC cleanup o f biological extracts including 
flash silica chromatography and size exclusion chromatography. One o f the compounds 
characterised has proven to have different stereochemistry to that expected based on 
previous knowledge. The structure, including stereochemistry o f  this new compound was 
obtained by a combination o f a process o f elimination (spiking studies) and by NMR 
spectra.
A comparative study o f  the effectiveness o f HPLC-MS and GC-MS for the accurate 
quantification o f triketide lactones has shown that GC-MS is the more preferable method 
having lower detection limits for this particular group o f compounds.
The synthesis o f  a A-lactone is also described (this was used as a standard in both 
quantification and spiking studies).
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Chapter 1 
Introduction
This chapter will briefly introduce the polyketide family o f  natural products and their 
biosynthesis, and then discuss the analytical techniques employed in the work described in 
this thesis, namely mass spectrometry, gas chromatography and high performance liquid 
chromatography.
1.1 Polyketides
Metabolism may be divided into two areas, primary metabolism and secondary 
metabolism. Primary metabolism usually refers to the biological synthesis o f  chemical 
compounds that play an essential role in the life o f the organism producing them, for 
example sugars, lipids and o f  course DNA. Secondary metabolism mainly refers to the 
biological synthesis o f compounds that may appear to have no noticeable benefit to the 
organism producing them. However, on closer inspection many secondary metabolites do 
show some function. Also, compounds such as pheromones may not be o f direct use to the 
cell but may be o f fundamental importance to the organism as a whole. These secondary 
metabolites are often created in times o f stress or hardship. 1
The main area o f concern in this thesis is with the group o f natural products known as 
polyketides.
The name polyketide is used to describe a large group of naturally occurring secondary 
metabolites that are both structurally diverse and yet have a number o f features in 
common.2 The similarity o f these polyketides derives from the simple building blocks that 
go into forming their sometimes quite complex structures. This comes about by the 
successive Claisen-type decarboxylative condensation o f malonyl or substituted malonyl 
thioester derivatives with units derived from the coenzyme A thioester o f carboxylic 
acids,3 leading to an iterative two-carbon chain extension. It is this way o f  building up the 
carbon skeleton which is used to classify polyketides.2
2
Complex polyketide biosynthesis occurs within multifunctional enzymes in a similar way 
to fatty acid synthesis. These enzymes are called polyketide synthases (PKS) and can have 
molecular weights in excess o f 300,000.4
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fig 1.1.1 Fatty-acid synthase.5 The central protein is ACP. The phosphopantetheine side chain serves to 
carry acyl groups from one enzyme area to the next
Polyketides may be divided into two main categories, the aromatic and the aliphatic. 
Aromatic polyketides are normally biosynthesised on type II, or iterative, synthases. Fatty 
acid biosynthesis (fig 1.1.1) occurs in much the same way as polyketide biosynthesis, in 
that they both proceed by a repeating iterative process around a single modul.5 
However, unlike fatty acid synthesis, where the chain extender residue is fully reduced 
each cycle, aromatic polyketide synthases do not possess any reductive capabilities so the
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resultant chain has a full keto group at each chain link ^-position (1) (fig 1.1.2). This 
excess o f  keto groups along the chain facilitates aldol or Claisen type intramolecular 
condensations and hence the formation o f an aromatic polyketide. Aliphatic polyketides, 
however, are often biosynthesised on type I, or modular synthases where the growing chain 
is passed along the enzyme from module to module, each one adding an extension residue. 
In these systems, each module can have varying levels o f  reductive capability. The 
structural diversity observed in aliphatic polyketides arises from the varying degree of 
reduction that each link may undergo at the P-carbon position (fig 1.1.2) to hydroxyl (2), 
alkenyl (3) or methylene groups (4), after it has been attached to the chain. Unlike fatty 
acid biosynthesis where the link is fully reduced after each condensation step, the modular 
polyketide synthase consists o f discrete areas o f enzymatic activity for every step o f chain 
growth.
The Archetypal Poty-ft-keto Chain Structural Variations Produced by Reduction at Keto Groups
fig 1.1.26
These areas or modules are arranged along the enzyme in the order in which they are 
utilised. Within these modules is a series o f smaller domains, which determine the 
structural nature o f the resultant polyketide. These domains are analogous to ketosynthase 
(KS), acyltransferase (AT) and acyl carrier protein (ACP) on the fatty acid synthase (fig 
1.1.1), all o f which are essential to the chain extension cycle. Each module on the aliphatic 
polyketide synthase (fig 1.1.3) also contains a number o f optional domains, the 
ketoreductase (KR), dehydratase (DH), and enoyl reductase (ER), which are responsible 
for the modification o f the newly formed keto group.7 The thioesterase (TE) domain is
1 2 3 4
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responsible for catalysing the cyclisation reaction o f the fully formed chain prior to its 
departing the enzyme. Each o f these domains performs a different and very distinct role 
and it is the varying combination o f  these domains within each chain extending module 
which gives rise to the vast degree o f structural diversity o f  polyketides not only in terms 
o f the level o f reduction but also stereochemistry.
An important example o f is the 6-deoxyeryth ronolide B synthase (fig 1.1.3) or DEBS 
produced by the bacterium Saccharopolyspora erythraea8 This multifunctional enzyme 
complex is made up o f three proteins9 known as DEBS1, DEBS2, and DEBS3. These 
enzymes are responsible for catalysing the biosynthesis o f the macro lactone 6 - 
deoxyerythronolide B 10,11, the skeleton for the antibiotic erythromycin A. The DEBS 
proteins, or cassettes, each incorporate two chain extension modules, each o f which is 
responsible for adding one methylmalonyl-CoA chain extender unit (fig 1.1.4), giving six 
in total to form seven links in all (a heptaketide). In each o f these modules are the domains 
necessary to build the macro lactone, or macrolide as it is more commonly known, in the 
required way. In the case o f S. erythraea, there are certain post-PKS reactions that, among 
other things, add sugars to turn 6 -deoxyerythronolide B into the antibiotic erythromycin 
A .12 Erythromycin A belongs to a larger family o f macrolides which is characterised by 12, 
14 or 16-membered rings.2 It was first isolated from Saccharopolyspora erythraea in 1952* 
and is used as an antibiotic against Gram positive bacteria such as Legionella pneumophila, 
the bacterium which causes Legionnaire’s disease.
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In order to investigate the underlying mechanisms that control stereochemistry and 
substrate specificity within these multifunctional enzymes, it is useful to have available a 
simplified form o f a PKS. This can be achieved in the form o f a triketide synthase, a 
truncated form o f  the erythromycin PKS consisting o f one o f the DEBS cassettes. The first 
triketide synthase to be genetically engineered was the so-called DEBS 1-TE13 (fig 1.1.5).
DEBS 1 TE: The first modified PKS
DEBS1 ' '
module 1 m odule2 end
KR KR,
[AC IATÏACR KSÏAT [ACM KS I AT
'OH
"""OH
OH OH
fig 1.1.5. The lactones produced from DEBS 1-TE are known as the ‘narmal’ lactones (normal
stereochemistry)
This involves the DEBS 2 and 3 enzymes being removed and the thioesterase, the module 
thought to be responsible for the cyclisation o f the lactone, being moved from the end of
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the DEBS 3 enzyme and brought to the end o f DEBS 1. This proved very successful and 
the resulting triketide was bio synthesised in vivo in quantities comparable to that o f the 
original erythromycin. It was also shown that the stereochemistry o f this resulting triketide 
lactone was also shown to have the expected stereochemistry corresponding to that area o f 
the erythromycin PKS, as predicted by Celmer14 (see page 9). When a construct was made 
consisting o f the DEBS 3 cassette with the loading domain from DEBS 1 and the 
ketosynthase from module 5 (KS5) replaced by KS, (this construct forms an integral part o f 
this thesis and will be discussed in more detail in the second section), it was found to 
produce the expected product in only very small amounts (<4mg/dm3). It was also seen to 
produce a range o f other stereoisomers within the culture broth. Modules have also been 
successfully incorporated into DEBS derived systems.15,16 Modules or domains from the 
rapamycin and avermectin PKSs are sometimes used as ‘spare parts’ to modify DEBS 
derived PKSs. For example, when the domain AT from module 1 in DEBS 1-TE is replaced 
by the AT from rapamycin module 2, a triketide lactone is observed where the methyl 
group at the 4-position is missing.17 This is because the AT: from the rapamycin PKS 
specifies a malonate extender whereas the DEBS AT; specifies a methylmalonate. 
Manipulation can also be carried out at the genetic level with regards to the functionality o f 
the various domains. For example, the second ketoreductase module KR] in the 
aforementioned DEBS 1-TE was deactivated. This had the effect o f eliminating reduction at 
the 3-position o f the resultant triketide lactone. Therefore, where a hydroxyl group would 
normally be seen, a keto group is now observed. Production levels o f this triketide lactone 
were quite high but still less than expected.
The construction o f these hybrid polyketide synthases opens many new doors in the field 
o f genetic engineering o f new type I PKS systems. The possibilities for new hybrid and 
truncated systems are almost limitless, leading to new antibiotics, immunosuppressants and 
other important compounds.
Since the triketide PKS DEBS-1 TE was first genetically engineered, many other truncated 
PKSs have been engineered in order to produce a variety o f different lactones, each o f 
which requires both molecular characterisation and quantification. Quantification o f these 
lactones is important since the efficiency o f  enzyme production is o f fundamental interest.
When the macrolide antibiotics are displayed alongside each other, there can be seen to be 
a marked similarity between the stereochemistries o f the alkyl and oxygen functionalities 
at any point along the chain (fig 1.1.6). This similarity, first noticed by Celmer, would 
indicate that each chain extension module extends the chain in an absolute stereochemical 
way. The stereochemical similarity between these sometimes quite complex macrolides 
seems to suggest that the polyketide synthases have similar properties and may have 
common evolutionary origins.14
Pre lactone Corresponding
macrolide
12-Membered
macrolide
(methymycin)
14-Membered
macrolide
(erythromycin)
16-Membered
macrolide
OH 0 OH 0 (tylosin)
fig 1.1.6. Celmer first noticed stereochemical similarities along the chain
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1.2 Mass spectrometry
In mass spectrometry there are three main stages that a sample must undergo before it can 
teach us anything useful. The first is the ionisation step. For this to occur, in most cases the 
molecules need to be in the gas phase (except where the volatization process produces ions 
directly). Secondly, the resultant ions must be separated according to their mass. In 
practice however it is only possible to separate ions according to their mass to charge ratio 
(m/z) but we may assume in most cases that z, the integer charge, is one since multiply 
charged ions are rare compared to singly charged ones in the mass spectra o f smaller 
molecules. We may therefore assume that the value o f m/z is the mass o f the ion.18
Ionisation techniques
Ionisation may be described in terms o f its hardness. This refers to the extent to which 
fragmentation o f the target molecule occurs during the ionisation process.
Electron impact (El) consists o f bombarding the sample with electrons, and is a so-called 
‘hard’ ionisation method. This means that the electrons delivered to the sample are o f such 
high energy (usually 70 eV) that the molecule spontaneously fragments and sometimes 
little or no molecular ion is formed. The decomposition o f the molecular ion in this case 
can happen in a number o f ways, from the low energy rearrangement o f bonds, to the 
relatively high energy homolytic breaking o f single bonds. El is particularly useful for the 
analysis o f smaller molecules which are relatively volatile since the sample must be in the 
gas phase. The El source is easily interfaced with gas chromatography because the eluting 
compounds entering the source are already in the gas phase.
Chemical ionisation (Cl) is by definition a softer ionisation technique in which the source 
region is flooded with a reagent gas. The reagent gas is by far in excess compared to the
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sample. When the ionisation chamber is bombarded with electrons, the reagent gas 
molecules (being more numerous) are ionised first. The primary radical ions generated 
undergo ion-molecule interactions to generate even-electron species which in turn cause 
secondary ionisation o f the sample molecules, 
e.g. N 113 + e" —> NH3.++ 2e", NI 13 + NH3. —> NH4 + NH2.,
NH4+ + M ^  MNH4+
Using this method, there is a greater chance o f observing the molecular ion. 19 Cl is often 
used as a complementary method to El. Since these methods are limited to compounds in 
the gas phase, a heated inlet probe may be used to somewhat increase the range of the 
technique.
Electrospray ionisation (fig 1.2.1.) has, in recent years, opened new doors to the 
analytical chemist in terms o f the analysis o f high molecular weight compounds such as 
proteins and polymers with masses o f over 100,000 Da.20 This ionisation method allows 
good mass spectra to be gathered from very small molar concentrations. The main reason 
that the electrospray technique is so suited to large molecules is that it has the almost 
unique ability to produce multiply charged ions.20 This series o f very large, highly charged 
species may then be analysed by a large variety o f mass spectrometers. The spectrum may 
be deconvoluted to give a molecular mass which is more accurate because it is an average 
value taken over a series o f peaks. Samples ionised by electrospray must be in solution. 
This feature means that an electrospray source may easily be coupled to various types o f 
liquid chromatography, the most common today being high performance liquid 
chromatography. Electrospray is a very ‘soft’ ionisation technique.21 This means there is 
little fragmentation and we may easily see the peak which corresponds to the molecular 
ion.
11
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fig 1.2.1. Schematic of electrospray ionisation20 
A very high potential is applied to the tip o f a needle, through which is ‘sprayed’ the 
sample solution. This high potential induces the same charge at the surface o f the droplets. 
These droplets are then repelled from the needle tip towards an oppositely charged plate. 
As this happens, the solvent evaporates making the droplets smaller but with the same 
surface charge. This increased surface charge density causes repulsion at the surface. 
Eventually when the droplets reach their Rayleigh limit (the point at which Coulombic 
repulsion exceeds surface tension) the droplet will explode. This cycle is repeated until all 
the solvent is evaporated and we are left with single, solvent free, ions.20
Mass analysis
Once the sample has been ionised, it must undergo mass separation or mass analysis. This 
may be achieved by a number o f methods outlined below.
The basic theory behind time of flight mass spectrometry is probably the simplest to 
understand. All ions are extracted from the ionisation source (ionisation may take place in 
a number o f ways) and accelerated by a pre-set potential difference. Because all the ions 
are subjected to the same potential difference, the kinetic energy to which they are then 
accelerated is proportional to the charge on the ion. 19,18 The amount o f time taken to travel
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the length o f the chamber, or field-free drift zone, is therefore proportional to the mass to 
charge ratio of the ion. One problem facing this method o f mass analysis is that the ion 
should ideally have no kinetic energy to start with so that all the ions will be accelerated to 
the same kinetic energy. In practice however the nature o f most ionisation methods means 
that the resultant ions are moving in a random manner with a range o f kinetic energies. 
One way in which this problem may be overcome is by accelerating the ions in a certain 
direction along a tube so that only the ions o f little or no kinetic energy in the direction 
perpendicular to the direction o f motion reach the end o f the tube. The ions may then be 
accelerated in the direction perpendicular to the motion along the field-free drift zone all 
with the same kinetic energy. Reflectron instruments are often used to effectively increase 
the path length o f the field free drift zone and so increase resolution and sensitivity.
ion s o u r c e
d e t e c t o r
rods
fig 1.2.2. Quadrupole mass analyser (opposite rods have similar charge)18 
The quadrupole (fig 1.2.2) mass spectrometer works in a very different way to the
conventional magnetic sector instrument (see later). Firstly, it does not require the ions to
be accelerated to high energies in order to separate them according to their mass. Only a
few volts are used to accelerate the ions before they enter the quadrupole. This consists o f
four parallel, cylindrical rods. Rods opposite each other are connected and a voltage
applied between the two pairs o f rods. An ion travelling down the centre o f the rods will be
repelled equally by the oppositely charged rods and so held in an energy minimum or
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valley along that plane. However it will be attracted equally by the similarly charged poles 
in the other plane and so is at an energy maximum or hill along this plane. A combination 
o f RF and DC voltages is applied to the poles. The amplitude o f the motion away from the 
central path depends on the magnitudes o f the RF and DC voltages and the mass o f the ion. 
It is possible to tune the voltages so that ions o f a desired mass reach the detector at the end 
o f the quadrupole and are not lost to the sides. 18 The quadrupole is not as accurate as larger 
sector instruments but has the advantage o f being relatively cheap, small and ideal for 
routine bench-top analysis.
The ion trap analyser works by creating a field inside the trap similar to that o f a 
quadrupole instrument. There are two end cap electrodes and one doughnut shaped ring 
electrode. However unlike the conventional quadrupole instrument, where the ions travel 
along the analyser to the detector at the end, the ions are trapped in a stable oscillating 
trajectory within the cell22. Then the various voltages across the electrodes are altered, and 
this has the effect o f destabilising the trajectory o f certain ions according to their mass. 
These destabilised ions are then ejected from the trap and detected23.
14
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fig 1.2.3. Schematic of a single focusing magnetic sector mass analyser18
In the magnetic sector instrument (fig 1.2.3) ions are accelerated by a potential difference 
which may be as high as 10 kV. The ions are made to converge on the entrance slit o f the 
analyser by a pair o f focussing plates. The kinetic energy eV given to an ion is given by 
eV=1Amv2. So singly charged ions entering the analyser all have the same kinetic energy. 
However ions o f different masses must be separated. This is achieved by applying a 
magnetic field perpendicular to the direction o f motion. This magnetic field will exert a 
force on the ion perpendicular to both the original direction o f motion and the applied 
magnetic field. The deflected ions will then travel in a circular motion o f radius r. The 
value o f r is proportional to the mass o f the ion and also to the magnitude o f the magnetic 
field B. So by varying B it is possible to separate out the ions according to their mass.23
15
1.3 Gas Chromatography (fig 1.3.1)
Chromatography is the separation o f mixtures o f compounds by the partitioning or 
distribution of those compounds between two different phases24.
The various compounds in a mixture are carried along by a mobile phase across a fixed 
stationary phase. The components partition to different extents and so are retarded by 
different amounts depending on their physical and chemical characteristics. The 
compounds with greater solubility in the stationary phase will be retarded to a greater 
extent and so will take longer to reach the detector. In capillary gas chromatography, the 
mobile phase is an inert gas and the stationary phase is usually a high molecular weight 
liquid, which is deposited onto the inner surface o f a length o f long fused silica capillary 
tubing
Sam ple , _
Carrier G as |  r - -------- H ea ted O y en ------------ ,  D etector " e ^ r d e r
(H z.H eNg) GC Column
Controlled Infection-------- -------------------
Port . - ^ piim Chromatogram
iWCOT Column
Liqu^
— 0.2 mm i ------
Capillary Tubing
24fig 1.3.1 A basic GC setup 
Sample introduction
The first rule for introduction o f the sample onto the column is that it must be in the vapour 
state. The most common method o f achieving this is by the use o f a self sealing septum, 
through which is injected the sample into a heated injection port. The sample, usually in 
solution is collected onto a sorbent material within the injection port (fig 1.3.2), is 
thermally desorbed, and introduced onto the GC column under the influence o f the carrier 
gas. The step o f thermal desorbtion is a very important one and must take place quickly 
and evenly24. The sample needs to be introduced onto the head o f the column as a thin
16
band and the sample injected must be a true representation o f the original mixture, in terms 
of relative amounts o f individual compounds. To allow the sample to be desorbed quickly 
the injection port will usually contain a small plug o f silanised glass wool. This serves to 
increase the effective surface area o f the injection port and so make sample desorbtion 
much quicker and more even. It is important that the injection port liner and glass wool are 
silanised and that the temperature is carefully monitored as active sites coupled with too 
high a temperature may facilitate sample degradation. The proper injection technique will 
serve to improve the quality o f peak shape and so make quantification more accurate. It 
will also make the measurement o f relative retention times o f the compounds in the 
mixture more accurate.
Syringe
Septum
Septum retainer
Heated block
Oven linerCarrier gas-c»— .
Column
fig 1.3.2. Typical flash vaporisation sample injector24
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Sample criteria
The concentration and amount o f sample which is loaded onto the head o f the column is 
also very important. If  the concentration o f sample is too high then the column will become 
overloaded. This will cause 'fronting' where the peak tails towards the front. The sample 
amount for fused silica capillary columns needs to be no greater than about lOOng per 
component and preferably about 50ng per component to avoid column overloading. If, 
however, there is too much sample solution introduced, then the sample will not be 
vaporised homogeneously and there will be peak 'tailing' where the peak tails towards the 
rear. The usual volume for a normal splitless injection is about 1 pL. It is possible to inject 
up to 100 pL at a time using a large volume injector apparatus 
Sample separation
Once the sample is vaporised and introduced onto the head o f the GC column, it is carried 
along by the pressure o f the carrier gas. This must be a relatively inert gas such as helium 
or nitrogen. The gas flow rate and pressure are carefully regulated by a series o f valves and 
regulators. When the separated compounds reach the end o f the column, they are detected 
by some means. The response o f the detector plotted against the time taken to reach the 
detector constitutes the gas chromatogram. This chromatogram can give us information 
about the eluting compound. The peak retention time gives qualitative information and the 
peak itself can give quantitative information from its area25. The flame ionisation detector 
is probably the most universally used, however the mass spectrometer, although more 
expensive, gives more information about the eluting compound. Whichever detection 
method is chosen for a particular piece o f analysis, the detector must be insensitive to the 
carrier gas.
The split injector is a useful device as it allows the use o f samples more concentrated than 
can normally be analysed effectively. The sample is vaporised in the injection port in the
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normal way but is split unequally (normally about 100:1). The larger fraction is vented to 
waste while the smaller one is carried onto the column. However, if quantitative 
information is required then the exact split ratio must be known. This can be measured 
either electronically or by the more usual bubble-in-a-tube method.24 
The gas chromatogram is also an important indication o f how efficiently the GC 
instrument is performing. Basic physical phenomena may be described by theoretical 
parameters that, when altered, can greatly improve separation and peak width.24 
There are three main parameters which go to make up equations that give information 
about the efficiency o f the column. The first o f these parameters to be measured is the 
elution time o f an unretained peak tm. This may be the solvent front or may be measured 
using a gas such as ammonia and a stopwatch. The gas is injected onto the column and the 
time taken to show on the mass spectrometer is measured. The second parameter is the 
retention time o f the peak o f interest tj. This is simply read off the chromatogram. The third 
is the peak full width at half maximum FWHM Wj. This is a measurement, as the name 
suggests, o f the width o f the peak in seconds, at half the height. Column temperature, 
carrier gas flow rate and column can greatly effect the quality o f the resultant 
chromatogram. By changing these in varying amounts it is possible to achieve the best 
results. But how is it possible to measure how well a chromatographic set up is 
performing? Using the simple measurements described it is possible to work out the 
number o f theoretical plates N by the relationship:
N =5.54(tj/w j)2
This value shows the column efficiency in producing narrow peaks. The smaller the peak 
spread, the larger the value o f N and the more efficient the column.
19
The resolution Rjj between two peaks (how easily the column separates them) may be 
calculated from the equation:
Rij=2[(tj-ti)/(wj-W i)]
Where tj and wj are the retention time and FWHM respectively o f a second peak.
A useful equation to describe the efficiency o f a column in terms of various physical 
properties was proposed by Van Deemter:24
h = A + B/u + Cu
h is the column efficiency (lower number indicates higher column efficiency), 
u is the carrier gas flow rate
A, B and C are various coefficients which make adjustment for molecular diffusion 
through the column, the effect o f different path lengths along the column and mass transfer 
between the mobile and stationary phases.
If for example a plot is made o f  u against h, it may be seen that there is a certain value o f u 
where h is at a minimum. This is the optimum flow rate for this column. It also shows how 
increasing the gas flow rate and so speeding up the experiment will affect the quality o f the 
results (quality may sometimes need to be sacrificed in favour o f time).
The Van Deemter equation as it is shown above was first derived when packed columns 
were in common use. An ideal case would be a column with no packing but with the 
stationary phase merely coated thinly onto the inner wall.
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Later generations o f the Van Deemter equation have been adapted for capillary GC 
columns and it can be seen from these that h oc r2 where r is the internal radius o f the 
column. Therefore, the thinner the column, the more efficient the chromatography. Today, 
columns have internal diameters sometimes as sm^ll as 0.2mm. The limiting factor here is 
physically making them thinner and still having them work effectively.
Today, GC instruments can be bought relatively cheaply and can easily be coupled to most 
mass spectrometers. They are small and can easily fit onto a bench top, the columns are 
easy to use and change and are flexible enough to be coiled round and made to fit in the 
most awkward o f spaces. Because the column is a capillary it may be connected to the 
mass spectrometer simply by inserting it directly into the source. With the advance o f 
computers, data processing has also become a more simplified affair. Gas chromatograms 
can be zoomed in, mass spectral data can be accessed simply by clicking on the required 
peak and calibration plots can also be made automatically. Peaks can also be integrated 
electronically instead o f the traditional method o f cutting them out from the paper and 
weighing them. The GC instrument itself can now be fully controlled from the computer 
workstation. Individual methods containing mass spectrometer tune files, GC temperature 
programs, gas flow rate and many other parameters can be stored as a single program and 
can be recalled instantly. GCs have become very important analytical tools to everyone 
from the biologist to the synthetic chemist and almost all laboratories have access to one.
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1.4 High Performance Liquid Chromatography
The basic principles o f separation which lie behind high performance liquid 
chromatography (HPLC) are very similar to those o f GC and, indeed, many other types of 
chromatographic separation techniques such as tic. Many o f the equations for HPLC, such 
as resolution and column efficiency, have much the same form as GC, as might be 
expected. However in this discussion, it is mainly the differences that will be dealt with, as 
these are what allow HPLC to be used beyond the usual limits o f GC.
S o l v e n t
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fig 1.4.1. A block diagram of the workings of an HPLC system26
In HPLC, the mobile phase becomes more important as interaction between it and the 
solute is more selective. In GC, however, all the sample vapours are soluble in all 
proportions because the mobile phase is a gas. This makes HPLC more selective and more 
able to perform more difficult separations.27
22
e lu e n t e lu en t
in out in out
va lve ro tor
out inoutin
sample sample
sampling p o s it io n  —>60°  r o t a t io n —>in je c t  p o s it io n
fig 1.4.2. An HPLC sample loop valve. The sample solution is placed directly into the solvent flow26. 
Sample introduction
The sample in liquid solution is introduced onto the head o f the column. Because o f this, 
the type o f sample which may be loaded is only limited to how easily it can be dissolved. 
Most substances will dissolve in something so this is not usually a problem, however if the 
sample is to be a true representation o f the original then a solvent must be chosen into 
which everything o f interest will dissolve. Because there is no thermal desorption, there is 
no danger o f decomposition so thermal stability and volatility are not factors. This means 
that unlike GC, HPLC may be used for a very wide range of compounds right up to 
proteins with molecular weights o f many thousands. It can also be used for compounds that 
are thermally quite unstable28.
The sample is usually applied to the column by means o f an injection loop (fig 1.4.2). This 
consists a loop which may be filled with a set volume o f analyte solution which is switched
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by a valve. This places the loop directly into the flow o f the solvent and the solution is 
washed straight onto the column.
The solvents are pumped from the solvent reservoir into a mixing chamber. When the 
solvents meet each other at high pressure (high pressure mixing), dissolved gases can come 
out o f solution causing bubbles to form. These bubbles can have a disastrous effect on the 
separation and retention times o f eluting compounds and can ruin expensive columns. This 
can usually be resolved by degassing solvents properly before use. Solvent sparging is the 
most common method. This involves bubbling a gas such as helium through the solvent for 
a time before use. Another way is by sonication, and a third is by filtering the solvent 
under a vacuum. When the solvent mixing chamber is set up before the pump (low 
pressure mixing) then this problem is greatly reduced although degassing is still advisable.
wa.Xl st; t'es am 1 ±ne s t a t i o n a r y  mofc> i  ZLe
zon-e z o n e
fig 1.4.3. A cross sectional view o f an HPLC column27
Column and packing
The HPLC column (fig 1.4.3.) is a precision piece o f equipment. It is generally a piece o f 
stainless steel tubing 10 to 25cm in length and about 0.5cm in diameter depending on the 
application. The packing is made o f small supports with an average diameter o f about 
5pm, onto which the stationary phase is coated. The most common coating is probably 
octadecylsilane or ODS; this is also known as a C-18 column.29 Silica is also used as a 
stationary phase. The fact that the particle size is so small and that the particles are packed 
in so tightly (pressures used to pack columns are sometimes in excess o f 700bar) means 
that the solvent pressure through the column must be high (about 150bar).
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Reverse and normal phase
The ODS stationary phase mentioned earlier is used in what is known as reverse phase 
HPLC. This means that the stationary phase is o f low polarity and the mobile phase is o f 
medium to high polarity. The solvent used here is usually water (or buffer) mixed with 
methanol or acetonitrile (either isocratically or as a gradient). This means that the 
compounds which are most polar will be eluted first and in order to increase the retention 
time o f the solutes one must increase the mobile phase polarity. In normal phase HPLC, 
silica columns are often used, giving a highly polar stationary phase. The mobile phase 
polarity must therefore be low to medium. For this hexane or heptane are usually used in 
conjunction with chloroform or dichloromethane. The solutes elute in the opposite order to 
that o f reverse phase HPLC and to increase retention time one must decrease the mobile 
phase polarity. Reverse phase utilising a C-18 ODS column is by far the most common 
HPLC set-up today. This is because reverse phase HPLC allows samples with a wide range 
of polarities to be analysed. It is also generally easier from an experimental point o f view, 
being faster and more reproducible than normal phase. However reverse phase is not 
without limitations. Firstly, it is only suitable for pH conditions o f between about 3 and 8 . 
Outside these limits the stationary phase starts to degrade. Secondly, the peak shape and 
reproducibility are sometimes not good because o f the ‘bleed’ o f unreacted silanol groups 
from the column. Thirdly, the mechanism for reverse phase retention is not fully 
understood, and this can cause problems when attempting to optimise separation from a 
theoretical point o f view.
One o f the most useful applications o f HPLC is the ability to carry out precise preparative 
separations.30 Corresponding preparative columns are usually commercially available for 
most analytical columns. The ideal is that only the flow rate need be adjusted to obtain the 
same results as the corresponding analytical column but on a larger scale, but it is not
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always as simple as this and a certain amount o f adjusting o f various parameters is usually 
appropriate. The fact that HPLC is so precise, and that it is very rare that two peaks cannot 
be resolved given a little investigation means that even small quantities (sometimes less 
than Img) of a mixture of compounds with very similar retention times may be separated 
and collected for further analysis such as NMR spectrocopy. An important consideration 
when performing preparative HPLC is that it should be looked on as a final, fine isolation 
method. That is, the compound or compounds o f interest must be as pure as possible before 
the preparative HPLC step is carried out, especially if the impurities are in larger quantities 
than target compounds. This preliminary purification can usually be achieved by some 
other more crude means of LC, such as a flash silica column or size exclusion LC. In 
preparative HPLC, if a solvent is chosen where some o f the impurities are insoluble then 
this can in itself act as a kind o f cleanup step (as long as the sample is filtered before 
analysis).
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Detectors
A good detector must have high sensitivity, because o f the problem of column overloading, 
and it must be able to distinguish the solute from the noise at very low concentrations. It 
must also show a good linear response. That is, it must show a response that is directly 
proportional to the amount or concentration o f solute eluting from the column.31 
Probably the most commonly used detector is the UV/VIS absorbance detector. The eluant 
passes through the small flow cell and the solutes are detected according to their 
absorbance. This detector will however, only detect solutes that absorb in the UV/VIS 
region (i.e that have a chromophore such as an aromatic ring or conjugated multiple bonds) 
at a fixed wavelength. Compounds with no active chromophore will not be detected. The 
diode array detector is a more advanced descendant o f the single wavelength uv detector. It 
allows a range o f wavelengths to be scanned at any point in the experiment and so makes 
the detection more universal. As in GC, the mass spectrometer is a more useful detector. It 
gives mass spectral data on every detectable peak eluted rather than simply indicating that 
the peak is there, as most other detectors do. Unlike GC however, the types o f mass 
spectrometer which may be used are limited. In most mass spectrometers, the sample must 
be in the gas phase before ionisation may take place. Because o f the nature o f HPLC and 
the fact that it is useful for larger, more involatile analytes, this is not always possible. The 
most attractive option for ionisation is therefore the electro spray ionisation source. This 
can give soft ionisation o f large molecules directly from solution, perfect for coupling to 
HPLC.
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1.5 Size exclusion chromatography
Size exclusion chromatography, or gel permeation chromatography (GPC) as it is 
sometimes known, is, in essence, the separation o f molecules according to their size. It 
differs from almost all other forms o f chromatography in that separation does not rely on 
any kinds o f physicochemical properties o f the molecule, the stationary phase or the 
mobile phase (other than that the samples must be soluble in it) but purely on the size of 
the solutes in relation to each other. Separation is achieved by means o f small porous 
particles or beads (fig 1.5.1). When the sample mixture is introduced to the column, 
molecules which are too large to enter the pores are excluded and pass along the column 
unretained. Molecules which are small enough enter the pores and are retained for a time 
before being eluted along the column (fig 1.5.2). Thus, mixtures o f molecules are separated 
in order o f their size.
Schematic o f a size-exclusion chromatography column
Porous
particles Column
Small Large 
molecule molecule
fig 1.5.1 Diagram of a size exclusion bead and fig 1.5.2 packed column 
When a biological culture is extracted into a solvent, along with the compounds o f interest 
(in this case triketide lactones) comes a large amount o f other undesirable contaminants. 
This may be from the growth media or cell matter such as lipids or protein. Before the 
target compounds may be analysed effectively, this unwanted material must be removed. 
In employing size exclusion chromatography certain assumptions are made. Most
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important is that most o f the contaminants (for example starches and lipids) are much 
larger in size than the lactones o f interest.
The column was packed with bio-beads obtained from Bio-Rad. These are porous styrene- 
divinylbenzene beads with an exclusion limit o f 1000 Da. The lactones to be separated 
have a mass o f 158-172 Da. The column was glass and was 1.5 m in length by 3 cm 
internal diameter. The beads were first swollen in dichloromethane, then poured into the 
column and eluted with dichloromethane. Once everything was set up, the crude extract 
was introduced to the column and pumped through with dichloromethane using a flow rate 
o f 5 ml/min. The eluant was detected by a uv detector set to 280 nm and collected in 20 ml 
fractions. The fractions were analysed by GC/MS and the lactones were found to be 
exclusively within two fractions. When these fractions were concentrated and run on the 
HPLC they were seen to be noticeably cleaner than before the size exclusion 
chromatography. The semi-pure fractions obtained from the GPC were then combined, 
concentrated to dryness and dissolved in acetonitrile : water mix ready for preparative 
HPLC.
1.6 Objectives
The main aim o f this study is to investigate the epimerase activity o f the erythromycin KS1 
when it is placed in an unnatural location at the beginning o f the DEBS3 truncated PKS 
system. In order to accomplish this it will be necessary to identify, quantify, isolate and 
characterise the novel triketide lactones biosynthesised by the system.
The lactones will be identified by GC/MS techniques. Two methods o f quantification will 
be evaluated. GC/MS and HPLC/MS methods will be compared with respect to limits o f 
detection, linear dynamic range and reproducibility.
Methods o f  extraction and isolation o f the lactones will be developed. A main focus o f this 
work will be the development o f preparatory scale reverse phase HPLC/MS using a 
FractionLynx mass spectrometer (Micromass, Manchester, UK.) with automated mass- 
dependent fraction collection.
Initial characterisation o f the lactones will be attempted by the use o f spiking studies in 
which samples are analysed by GC/MS with and without the presence o f  known lactone 
standards. It may be necessary to synthesise a lactone standard if one is required and is not 
available. Then it will be necessary to use NMR spectroscopy, coupled with molecular 
modelling studies, in order to investigate stereochemistry o f the biosynthetic products.
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Chapter 2 
Results and Discussion
2.1 Ery Load-KSi-DEBS3, the reason for this particular construct.
In preliminary experiments on the mechanism o f stereocontrol, it was proved that (S)- 
methylmalonyl Co A was used in both chain extension units o f DEBS 1. In contrast, (R)- 
methylmalonyl CoA was not utilised32,33 (fig 2.1.1). This showed conclusively that the 
control o f stereochemistry at the methyl branching centres was not exercised by selection o f 
the appropriate chiral form of the chain extension building block as had been proposed on 
the basis o f  in vivo experiments. Instead, the control must be exercised in the mechanisms 
of the chain extension processes themselves.
CoAS
S isomer always used R isomer never used
fig 2.1.1: Methyl-malonyl coenzyme A 
Subsequently, experiments were carried out with a labelled version o f  methylmalonyl CoA 
in which deuterium was located at the chiral centre33. The hydrogen isotope label was 
retained at the methyl-branching chiral centre in the chain extension residue produced by 
module 2 but was completely lost in the chain extension process carried out by module 1.
These experiments also showed that the chain extension reaction was carried out with 
inversion o f configuration in module 2. It was suggested, to explain the loss o f the hydrogen 
from the chiral centre in module 1, that the equivalent condensation step might also take 
place in the same stereochemical sense with inversion o f configuration to give the (2R)- 
isomer o f the keto ester and that this isomer would then be epimerised to the (2S)-isomer by 
énolisation prior to reduction by the KR domain (fig 2.1.2).
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4R
-►
R
(2S)
fig  2.1.2: Inversion of configuration and loss of deuterium  proceeds by énolisation  
These results demonstrate that module 1 holds the key as far as épimérisation is concerned.
What remained to be established after these experiments was the factor in module 1 which 
is responsible for the épimérisation process. We suspected that it might be the KS domain 
but, o f course, it could have been any of the other domains or even a part o f the protein in 
the reductive loop, which has not been assigned any specific function. In order to test the 
possibility that KSi might be an active participant in the épimérisation, a hybrid polyketide 
synthase was designed based on DEBS3 in which the first KS, KSs, has been replaced by 
KSi, and, to make the construct completely efficient, the loading domain was also 
incorporated at the front o f the truncated PKS. This is shown in figure 2.1.3 and for 
comparison the reported4 pattern o f behaviour o f modules 5 and 6  in an unmodified version 
o f DEBS3 is shown in figure 2.1.4.
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fig 2.1.4 Pattern o f  behaviour previously reported
Previous results suggested that one or both o f the KR domains in DEBS3 show a low degree 
o f stereo specificity in carrying out reduction o f the keto group o f a model keto ester. This 
observation raised the interesting possibility that one or both KRs might accept both 
stereoisomers o f the keto ester form of the diketide intermediate and so provide a very 
effective approach to probe the seat o f the épimérisation activity. Note that only one 
stereoisomer (uduu, see below) was reported by the Stanford group in in vitro studies with 
the unmodified version o f DEBS3.4 This lacked a normally functioning starter domain and 
KS5 in place of KS,, so it does not provide a direct basis for comparison with any results 
from our own experiments.
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Naming
Fig 2.1.5 below shows the simplified naming convention used in this report
2 
OH
4
2
OH
4
fig 2.1.5 shows how the stereochemistry o f triketide lactones will be specified within this 
report. With the ring in the plane o f the paper and the carbonyl group to the right, each 
substituent starting at 1 and going anti-clockwise will be either u or d.
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2.2 Quantification study
When studying the nature o f truncated or other genetically engineered polyketide 
synthases, a good indication o f how well or efficiently the new synthase is performing is 
by accurate quantification o f the metabolite product. If, as in the case o f S.erytharea wild 
type, the product is produced in the order o f grams, then it is probably enough to isolate the 
product on a silica column and simply weigh it. However, if, as is often the case with new 
constructs, the product or products are produced in the order o f milligrams or sometimes 
even less, then accurate quantification by GC or HPLC is required. The question remains, 
which o f the two methods is better for the analysis o f triketide lactones, in terms o f 
linearity across a good number o f orders o f magnitude, lower detection limits and 
reproducibility. The two instruments used within this study were the Finnigan-Matt GCQ, 
a GC coupled to a quadrupole ion trap with Cl source, and a Hewlett Packard 1100 HPLC 
system coupled to the LCQ quadrupole ion trap with electrospray source.
A weighed synthetic triketide lactone standard o f 2.2mg/ml was made up in methanol and 
serial dilutions were made from that stock using calibrated Gilson pipettes. The solution 
was diluted by half each time. These standards were then run on the LCQ and GCQ and the 
peak areas recorded (tables 2.2.1 and 2.2.3) and plotted against concentration o f standard 
(figs 2.2.2 to 2.2.4 ).
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table 2.2.1
Observed peak areas for varying concentrations o f standard on LCQ
LCQ Calibration standards
Conc(mg/ml) Peak area
2.2 2.9563xl07
1.1 1.4795xl07
0.55 7.5852xl06
0.28 3.8875xl06
0.14 1.9548xl06
6.9x10"2 9.5483xl05
3.4x102 4.6209x105
1.7x102 0
8 .6 x 10"3 0
4.297x10"3 0
2.148xl0"3 0
f i g  2 .2 .2
Calibration standard curve of normal propionate triketide lactone on LCQ
y = 1E+07X - 53421
R2 = 0.!
35000000
30000000
25000000
20000000
15000000
10000000
5000000
0 0.5 1 1.5 2 2.5
concentration (mgftnl)
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table 2.2.3
Observed peak areas for varying concentrations o f standard on GCQ
GCQ Calibration standards
Conc(mg/ml) Peak area
2.2 7.0250x106
1.1 3.3922xl06
0.55 1.6719xl06
0.275 8.1644xl05
0.1375 4.0922x105
6.875xl0"2 2 .0 0 2 2 x 10 5
3.4375xl0"2 1.0106xl05
1.7188xl0"2 5.1028x10"
8.597xl0"3 2.5614x10"
4.297x103 1.2698x10"
2.148x10'3 8.518xl03
fig 2.2.4
C alib ra tio n  s ta n d a rd  c u rv e  o f n o rm al p ro p io n a te  la c to n e  o n  GCQ  y _ 3 E+0 6 X - 23984
R2 = 0.9997
8000000
3e
!
The first significant thing to be noticed from the tables o f results is the fact that the LCQ 
could not detect concentrations as low as could the GCQ. This is as expected because the 
lactone has the ideal structure to be detected by GC-MS (small and o f ideal volatility) 
whereas the LCQ is more suited to larger molecules. It is clear that both instruments show
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good linearity with R2 values o f 0.9996 in the case o f the LCQ and 0.9997 in the case o f 
the GCQ. The GCQ however, shows this excellent linearity down to lower limits than the 
LCQ and over several orders o f magnitude.
From these results, it is clear that the GCQ is the better choice for both the quantitative and 
the qualitative analysis o f  triketide lactones. Another question however is that o f 
reproducibility.
The same standard concentration o f 4.297x10"3 mg/ml was injected ten times and the 
response factor was recorded (table 2.2.5):
table 2.2.5
Repeat injection o f 4.297x10"3 
mg/ml
Injection N ° Peak area
1 12605
2 12337
3 12332
4 12132
5 12095
6 12719
7 12755
8 12382
9 11566
10 12452
The mean value o f  the peak area is %=12338 where:
The sample standard deviation s = 331.5
i.e. a sample standard deviation o f about 2.7% at a concentration slightly above the 
minimum detection limit.
From this it is clear that the GCQ is a perfectly accurate and reliable instrument on which 
to quantify triketide lactones.
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The next step is to quantify the amount o f lactone actually produced by a construct, in this
case pO 15-5624 (Ery Load-KSs-DEBSS). The plates were prepared as described earlier
with a final extract volume o f 30ml. A Ip l splitless injection was made onto the GC
straight after the standards (in fact within the same run). The peak area o f the main
propionate peak taken from the mass 190 single ion chromatogram was measured and
found to be 228601. I f  we use the equation given for the calibration curve on fig 2.2.4:
Y = 3 x 106 x -2 3 9 8 4
Where ^^concentration (mg/ml) 
Y=peak area
then the concentration % is calculated to be 8.42x10'2mg/ml. There are 30ml o f extract so 
the total amount produced is 8.42x10*2 x 30 = 2.53mg. The total volume o f the plates was 
1.61 (8 x2 0 0 ml) so this particular construct produces the major triketide lactone on plates at 
1.58mg/l. This is a significantly small amount making isolation and characterisation an 
extremely difficult (but not impossible) task.
The value for the Y intercept (-23984) gives an indication o f the error associated with these 
experiments.
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2.3 A ’’Spiking" study
Plates o f the construct p015 5624 (ery load-KSi-DEBS3) were extracted as described in 
section 3.2. This crude extract was analysed by GC-MS (temperature gradient 40oC-145°C 
in 23 mins) on a 30m, 0.25mm ID Rtx-5MS capillary column (Thames Restek UK LTD, 
Windsor, UK) for the presence o f triketide lactones. From what is known about the 
polyketide synthase and how it builds up these metabolites, and also from previous 
studies4, we can predict that the expected product from this construct should be uduu. (fig 
2.3.2) shows the gas chromatogram total ion current in the top line, the single ion 
chromatogram o f mass 190, which corresponds to the propionate triketide lactone plus 
ammonia, (these lactones are detected as ammonium adducts as ammonia is the chemical 
ionisation gas used) is shown in the middle trace and the 176 single ion chromatogram at 
the bottom which corresponds to the acetate lactone plus ammonia. In the centre 
chromatogram corresponding to the 190 single ion chromatogram, there can be seen three 
peaks, one large one at 14:19 mins, and two smaller ones at 14:44 mins and at 15:04 mins, 
all o f  which have a mass spectrum typical o f a propionate triketide lactone. These three 
peaks must therefore be stereoisomers o f the propionate triketide lactone. This tells us 
straight away that the triketide synthase is behaving in a way that was unexpected.
It was important to try to determine the structure o f these lactones in terms o f 
stereochemistry. The first step was to try to match them with synthetic standards. This was 
done by spiking the chromatogram with a quantity o f a synthetic triketide lactone standard 
(prepared by other members o f the research group) o f known stereochemistry. The second 
chromatogram (fig 2.3.3) shows the same crude extract but with lOpl o f a 2.2mg/ml 
solution o f the propionate lactone uddd added. This clearly shows an enhancement o f the 
peak (2 ), which can be clearly seen in the 190 chromatogram (middle trace) for that
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experiment at 14:46. This leads us to believe that the second peak is uddd or its 
enantiomer.
Further spiking studies o f this nature using other synthetic standards (previously 
synthesised by other members o f the research group) has allowed the elimination o f other 
possible stereoisomers.
A second culture was extracted in the usual way (as described in section 3.2) but this time 
the mass 190 single ion chromatogram showed that there were two major propionate 
lactone peaks corresponding to peaks (1) and (3) o f the first culture with regard to the 
retention times. Five synthetic standards were available (synthesised previously by other 
members o f the research group except for duuu, the synthesis o f which is described in 
sections 2.7 and 3.4) and these were spiked one at a time. The first chromatogram o f the 
crude material was spiked with uddd. This showed an enhancement o f peak (2). The 
second spike of udud showed an extra peak allowing it to be eliminated. The third spike o f 
dudd showed an enhancement o f peak (1). This tells us that peak (1) is the dudd isomer or 
its enantiomer. The fourth spike o f stereochemistry duud showed the appearance o f an 
extra peak allowing this one to be eliminated. The final spike o f duuu showed an 
enhancement o f peak (2). An attempt was not made to isolate peak (2) as it was thought 
that the amounts produced were too low. Peak (1) and the synthetic standard dudd were 
successfully separated using a chiral column indicating that the first peak is the expected 
DEBS 3 triketide lactone uduu, the enantiomer o f the standard dudd. To summarise, the 
first peak is uduu and the second peak is duuu or uddd and the third peak is not udud, 
dudd, duud or duuu or their enantiomers (Table 2.3.1). So the question remains, what is the 
peak (3)? The first peak is clearly the expected DEBS 3 stereochemistry but the synthase is 
obviously producing something else. The next step was to attempt to isolate peaks (1) and 
(3) to verify their structure and stereochemistry.
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Table 2.3.1
Lactone Standard Observation
uddd Enhancement o f peak (2)
udud Appearance o f extra peak
dudd Enhancement o f peak (1)
duud Appearance o f extra peak
duuu Enhancement o f peak(2)
fig 2.3.2 Unspiked crude.
Chromatogram Plot D:\DOMINIC\DK226_l Date: 06/22/98 11:55:47
Comment : p015 5624 debs 3 crude extract at approx.25 ml 
Scan No: 802 Retention Time: 18:25 RIC: 459 Mass Range: 80 -  434 
Plotted: 297 to  901 Range: 1 to  1208 100% = 52717
9.23%
TOT-
190-
176-
A-
500 800700600400300
10:03 11:43 13:23 15:03 16:43 18:23
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fig 2.3.3 Spiked with normal propionate lactone (uddd)
Chromatogram P lo t D:\DQMINIC\DK226_2 Date: 06/22 /98  14:03:23
Comment : p015 5624 debs 3 crude 25 ml w ith  lO ul (lO ul 2.2ug/m l norm la c )
Scan No: 390 Retention Time: 11:33 RIC: 327 Mass Range: 54 -  438 
P lotted: 301 to  901 Range: 1 to  1208 100% = 46409
12%
TOT-
5.13%
190
176-
800700600500400
11:43 13:23 15:03 16:43 18:23
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2.4 Preparative HPLC
Initially, all preparative work was carried out on the HP 1100/LCQ. There were however, 
many problems associated with this. The HP 1100 is primarily an analytical instrument, 
mainly because it is only capable o f delivering a maximum flow rate o f 5 ml/min. When 
the preparative column was fitted, which should be used at 20 ml/min, peak shape and 
resolution were severely compromised. The length o f the run was doubled to try to 
improve separation but this was still unsatisfactory. It should be noted that the ions 
detected fly by electrospray as MKf.
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fig 2.4.1: 173 single ion chromatogram of extract pO 15-5624 run at 1 ml/min on analytical column. (lOfil 
injected. Grad=60%-90% acetonitrile in water over 30 min)
45
___
fig 2.4.2: 173 single ion chromatogram o f extract o f construct pO15-5624 run at 5 ml/min on preparative 
column. (500|il injected. Grad=60%-90% acetonitrile in water over 60 min)
It can be seen from figs 2.4.1 and 2.4.2, that the chromatographic separation achieved from 
the attempts to scale up from analytical (fig 2.4.1) to preparative quantities (fig 2.4.2) using 
an analytical instrument are quite unsatisfactory. Another problem that arose was the issue 
o f timing. The peaks were collected at the splitter by observing the computer screen and 
collecting the appropriate peak when it was seen, however this relies on the time taken for 
the solute to reach the mass spectrometer source and the test tube being exactly the same. 
As this is often not the case, peaks are often missed. Due to poor chromatography and the 
timing problem, very few compounds were isolated successfully.
t;
. . . .
Real advances were made when a Waters platform prep LC system became available. This 
gave high flow rates for preparative work and had fraction collection capabilities. Initially, 
with this system, no lactones could be detected under these conditions probably because o f  
the relatively high minimum detection limits o f electrospray LC/MS o f lactones when 
using the LCQ. A synthetic standard solution o f a triketide propionate lactone was infused 
into the source via a syringe pump and the instrument tuned to this signal. Once tuning had 
taken place, the analyte lactones were easily detectable. Scaling up to preparative levels 
was also much better and preparative runs were usually comparable to the corresponding 
analytical runs. It was found that the optimal gradient for the separations o f these lactones 
was 60%-90% acetonitrile in Water over 30 min. These conditions gave good base line 
separation allowing pure peaks to be isolated effectively.
Altogether two peaks, (1) and (3) (see fig 2.3.2) were successfully isolated from the 
construct pO 15-5624. The first peak isolated proved to have a NMR spectrum identical 
to that o f a synthetic standard produced earlier,37 which had the exact stereochemistry to be 
expected from the operation o f the DEBS 3 cassette, namely uduu. The NMR for the 
peak (3), from here on referred to as the unknown, is discussed in section 2.3 
Accurate mass by electrospray ICR-MS:
Peak (1)
(Found: Na-M% 195.09835. CgHigOgNa requires 195.09916).
Peak (3)
(Found : Na-M+, 195.09837. CgH^OgNa requires 195.09916).
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2.5 Interpretation of NMR Spectra35,36
As it is not possible to differentiate between pairs o f enantiomers o f the various triketide 
lactones by ]H NMR spectroscopy in non-chiral solvents, the pairs have been grouped 
together and each pair has been given a code from Lacsl to LacsS as follows:
OH
Lacs2
OH
OH
Lacs4
Lacsl
O ' i ^O r ' ^ o ^ ^ o
OH
OH
I Lacs3
o v
The first lactone shows the numbering convention used for NMR assignment.
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The pure unknown lactone, isolated by preparative HPLC, gave the following 800 MHz 
NMR spectrum:
Ôh(800 MHz, CDC13) 4.70 [ddd, 1H, J=2.9, 5.7, 8.5Hz, C(5)-H], 3.6 [d, 1H, ^=2.86Hz, 
C(3)-H], 2.67 [dq, 1H, ^ 3 .6 , 7.2Hz, C(2)-H], 2.10 [m, 1H, C(4>H], 1.81 [m, 1H, C(6)- 
Ha], 1.55 [m, 1H, C(6)-Hb], 1.36 [d, 3H^=7.24Hz, C(2)-CH3], 1.03 [i 3H^=7.5Hz, C(7)- 
H3], 1.01 [d, 3H ,^ 7.3H z, C(4)-CH3].
The hydrogen at C(2) gave a signal at 2.67 which consists o f a doublet (J=3.6) o f quartets 
(J=7.3). This shows that the coupling between the C(2)-H and the adjacent ring hydrogen 
at C(3) is 3.6. That means that the dihedral angle between C(2)-H and C(3)-H must be 
small (either equatorial-equatorial or axial-equatorial but not axial-axial). Computer 
molecular modeling using a silicon graphics 0 2  computer and the molecular modeling 
program Macromodel 5.5 (Schrodinger Inc. N.J. USA) was performed to calculate the 
dihedral angles between the adjacent prôtons on the various lactones. The results are given 
in table 2.5.1. From these, it was possible to eliminate Lacs2, Lacs6  and LacsS. The basis 
for this was given by Karplus35 and assumes that for two adjacent protons with a large 
dihedral angle i.e. approaching 180° for an axial-axial interaction, the coupling constant 
between them will be ca. 7.3Hz. For a small axial-equatorial or equatorial-equatorial angle
the coupling constant is about 3.6Hz.
Lac 1 Lac 2 Lac 3 Lac 4 Lac 5 Lac 6 Lac 7 Lac 8
Dihedral angle 
between 
hydrogens at 
€ 2  and C3
-60.2 144.1 52.1 60.9 68.1 -150.2 -69.4 -164.9
Dihedral angle 
between 
hydrogens at 
C3 and C4
64.1 40.5 60.2 -65.4 95,5 92.6 -64.6 -176.3
Dihedral angle 
between 
hydrogens at 
C4 and C5
-40:6 : -59.6 50.5 168.1 -153.9 62.6 169.1 -177.3
Tabic 2*5*1 Computer modelling prediction of the dihedral angles in the possible stereoisomers of propionate 
triketide lactones
49
OH OH
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H H H
OH OH OH
LacsS h £acs6  H Lacsl 0H LacsS h
The above structures give a clearer indication o f the dihedrals between adjacent protons.
Only one o f each pair o f enantiomers is shown as the angles are identical within each pair.
The ring hydrogen at C(4) gave a multiplet signal at 2.10. A second NMR experiment was 
then carried out were the signal was homodecoupled at 0.98 (the peak which corresponds 
to the C(4)-Me). The signal at 2.10 then consisted o f a triplet with coupling constant o f 3.5 
Hz. This would indicate that the coupling constants between the ring hydrogen at C(4) and 
the adjacent ring hydrogens at C(3) and at C(5) are the same value, (since the splitting 
from the methyl group hydrogens at C(4) was effectively eliminated) showing that both 
dihedral angles are small. The only stereoisomers where all three ring hydrogen dihedral 
angles are small are Lacsl and Lacs3. One o f the enantiomers o f Lacs3 has been 
synthesised previously37 and the ]H NMR spectrum o f the unknown triketide lactone was 
found to be identical to that o f the published data. O f the two possible enantiomers only the 
uudd (lacs 3) isomer is really plausible in terms o f the operation o f the triketide synthase. 
This is because with the enantiomer dduu, the change from the expected isomer uduu 
occurs in module 6  whereas with the enantiomer uudd the change occurs in module 5. This 
is more likely as this is where the change has been made. There is no reason to suspect that 
the change in KSi should affect module 6  but not affect module 5.
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2.6 Implications of results
There were two main propionate lactones produced. The first proved to be the stereoisomer 
(uduu) formed by the normal operations o f modules 5 and 6  which had been isolated 
earlier in studies on triketide formation by an unmodified version o f DEBS337. This result 
confirms that KSi can deliver the unepimerised (2R)-keto ester to its partner KR domain in 
the same module; The second major isomer which was characterised in chapter 2.9, was 
identical by proton NMR spectroscopy to another stereoisomer (uudd) isolated in earlier 
work.37 This differed from the normal product at the three chiral centres C-3, 4 ,5. The 
most significant point o f difference in the context o f the current investigation was the 
stereochemistry at C4 which corresponds to the (2S)-isomer produced by épimérisation o f 
the keto ester at the methyl branching site o f the diketide formed in module 5. Surprisingly, 
in accepting this opposite epimeric form o f the keto ester, KRs reduces the keto group not 
in its usual sense by hydride addition to the Re face to give the (3S)-3-hydrOxy product but 
in the opposite sense to give the (3R)-product (fig 2.6.1).
 IIOH
fig 2.6.1 hidride addition occurs at Si face
The unexpected reduction behaviour then continues in module 6 . The condensation
proceeds as expected to give the non-epimerised (2R)-keto ester but KR* then reduces this
*
by hydride addition not in its normal mode to the Re face but to the opposite Si face. 
Consequently, the stereochemical relationship between C2 and C3 in the second chain
extension unit is anti rather than syn. Remarkably, this altered stereo specificity in the 
reduction step is triggered not by alteration o f the configuration at the branching methyl 
centre generated in the current chain extension reaction, but by anomalous chiral centres 
generated in the previous chain extension module.
The most significant outcome o f these experiments, however, is the demonstration that 
module 5 can be turned from a non-epimerising environment to one capable o f  
épimérisation merely by transfer o f KSi to replace KS5. We believe that the two loading 
domains can be excluded from this role because o f the earlier work by Katz38 who showed 
that removal o f these domains from the front o f module 1 in the otherwise intact 
erythromycin PKS did not destroy the epimerising activity o f module 1. Our results clearly 
implicate KSi as the source o f epimerising activity, but it is important to stress that it 
remains to be proven that it produces this change by acting as an active catalyst o f the 
épimérisation process.
The results presented here demonstrate that épimérisation activity can be transferred from 
one module to another by genetic engineering but, depending on the character o f the 
receptor module, the outcome may be both surprising and unexpected.
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2.7 The need for synthetic standards
When carrying out any kind o f analysis, probably the single most useful thing to have 
available is a standard. It makes both qualitative and quantitative analysis much easier by 
transforming it from being almost trial and error to a simple matter o f comparison. This 
standard should be as close in structure to the analyte (or the expected analyte) as possible. 
In the case o f this report, most o f the standards used were o f the same structure (or 
expected structure) as the analyte but different stereochemistry. In doing this, certain 
assumptions were made concerning the nature o f the mass spectrometer. It was assumed 
that both standard and analyte would give the same response factor, that is, a given 
quantity o f one compound will give the same peak area as the same quantity o f another 
compound. Considering that the two compounds (analyte and standard) were so similar 
and only differed in terms o f stereochemistry it was thought that this was a reasonable 
assumption to make. Triketide lactones are not commercially available so all standards 
must be either synthesised or isolated from bacterial culture. The second is possible only if  
the compound is produced in large enough quantities but the first option is more favourable 
as it allows exactly the right standard to be made in any quantity.
An attempt was made to synthesise the propionate triketide lactone uduu39 (the expected 
lactone from the DEBS3 construct pO15-5624).
Fig 2.7.1 shows the proposed reaction scheme to obtain the appropriate lactone (7). The 
first step (a) is an aldol reaction. This was carried out under the conditions described in 
section 2 .12.1 in the presence o f  dibutylboron triflate, to form the dibutyl boron enolate o f 
chiral propionamide (1) The reaction proceeded successfully and the expected anti aldol 
product (2) was obtained. The second step (b) protected the hydroxyl group using tert- 
butyldimethylsilyl triflate to give (3) so that the phenylmethyl-2-oxazolidinone could be
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removed by reduction with lithium borohydride in the third step (c) to yield the free 
alcohol (4). This was then oxidised to the aldehyde (5) in the fourth step (d) using the 
oxidising agent tetrapropylammonium perruthenate (TPAP). When step e, the second aldol 
reaction was attempted under the same conditions the expected aldol product (6) could not 
be detected. It was thought that the reaction did not proceed because o f the incompatible 
stereochemistry between the chiral auxiliary (1) and the aldehyde (5) in undergoing an 
aldol reaction.
The chiral auxiliary (8) o f opposite configuration to that used in step e was then employed 
and the procedure performed under the same conditions as step e (step e'). This time the 
reaction was successful giving the aldol product (9). This was then cleaved and cyclised 
using lithium hydroxide and hydrogen peroxide (step f  ) to yield the propionate triketide 
lactone duuu (10) corresponding to lacs 2. Full conditions for this synthesis are described 
in chapter 3.4.
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X step (a) X
O OTBDMS
Step(b)
Ph
Chiral auxiliary (1)
Ph
1st aldd product (2)
A
Ph
protected hydroxy (3)
O OTBDMS t
Step(c)
H
OH OTBDMS
Step(e) Aldehyde (5)
Step(d)
Step(ef) Alcohol (4)
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Step(f) Ph
t
OH
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Step(f)
t
CH
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Adual final lactone (10)
Fig 2.7.1 Steps (a)-(d) show the steps successfully completed. Steps (e) and (f) were unsuccessful however
steps (e') and (f) were completed successfully.
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Chapter 3 
Experimental
3.1 SJM3 agar plates
This section describes the process by which the bacterium containing the particular 
construct was cultivated so that the desired metabolites may be produced in maximum 
yield
Constituents for preparation o f growth media
1. Glucose 8g
2. MD30E 80g
3. Soy Bean Flour 40g
4. Beet Molasses 4.8g
5. K2HPO4 0.4g
6. CaC03 4g
7. Agar 35.2g
The above ingredients were placed into a large beaker containing about one litre o f milli-Q  
water. The mixture was stirred and heated slightly for 20 minutes until everything had 
dissolved. The mixture was then made up to the 1.6 1 mark and stirred. The pH was taken 
with a pH probe and the pH adjusted accordingly with 1M KOH. The mixture was divided 
into 200 ml aliquots, which were placed into eight 3 1 conical flasks. These were stoppered 
and heated in an autoclave at 125°C for 1 hour.
When the autoclave cycle was complete and the media cool enough to touch (40°C), 
thiostrepton solution (200 pi, lOOpg/ml) was added. The media was then poured out into 
eight 500cm2 Petri dishes, allowed to cool and covered ready for inoculation.
Seed cultures o f the construct were prepared using tryptic soy broth (50ml) containing 
thiostrepton solution (lOp, lOOpg/ml). These Were inoculated from storage plates or frozen 
stocks and incubated and shaken at 30°C, 250 RPM for 3 days. The cells were cheeked 
under the microscope and if  the cell density was high enough, the plates were inoculated 
and left to grow at 37°C for approx. 2 weeks when they were extracted.
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3.2 Extraction of plates and liquid
This section describes the general procedure employed for the extraction o f bacterial 
culture.
• Plates
The first agar plate was sliced into 4cm2 squares with a spatula. These were 
transferred to a Waring blender bowl and 1% formic acid in ethyl acetate (200 ml) 
was added. This was blended for 10 seconds on low power. The mixture was left to 
stand for 30 seconds and then blended for a further 10 seconds on low power. It was 
left to settle again for 30 seconds and the supernatant liquid was decanted off. A 
further portion o f ethyl acetate (200 ml) was added and the plate extracted again. 
After a third extraction, the extracts were combined. This procedure was repeated for 
all the eight plates and all the extracts combined. Sodium hydrogen carbonate (200 g) 
was added and the extract effervesced quite vigorously. The extract was stirred with a 
magnetic stirrer until it was neutralised (usually about 2 hours) and was then filtered 
through coarse filter paper using a Buchner funnel. Sodium sulfate (200 g) was added 
to dry the extract. Once dry, the extract was again filtered through coarse filter paper. 
The dry, neutral extract was concentrated under reduced pressure ready for analysis 
and purification.
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Liquid
The liquid cultures were removed from the shaker and 3M hydrochloric acid was 
added to take the pH to about 2. They were then poured into 500ml centrifuge 
buckets, balanced and spun at 10,000 RPM for 2 hours. After this, the supernatant 
liquid was carefully decanted o ff and the cell matter discarded. All the liquid was 
combined and placed into a large separating funnel. Ethyl acetate (500 ml) was added 
and the funnel shaken for 1 min. The ethyl acetate layer was separated and the process 
repeated twice more with fresh portions o f  ethyl acetate. The ethyl acetate fractions 
were combined and sodium sulfate (200g) was added. The mixture was then filtered 
through coarse filter paper and the dry extract concentrated under reduced pressure 
ready for analysis or purification.
Preliminary purification o f crude extracts was performed either by silica gel flash 
column chromatography or by size exclusion chromatography.
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3.3 Isolation of Triketide Lactones from p015-5624 (Ery load-KSi-DEBS3)
This section describes the method by which this particular batch was grown and harvested. 
To yield the pure compounds discussed.
Bacterial seed cultures were plated out onto agar (500cm2 x 8) containing thiostrepton (50 
pl/ml). These were incubated at 30°C for 14 days until they turned a deep browny red 
colour. The plates were then extracted three times into ethyl acetate containing 1% formic 
acid, using a Waring blender. The extract was neutralised over sodium hydrogen 
carbonate, left to stir for 2 hours and dried over sodium sulfate. The mixture was then 
filtered and concentrated under reduced pressure to approx. 10 ml. This crude extract was 
analysed by GC-MS (temperature gradient 40oC-145°C in 23 mins) on a 30m, 0.25mm ID 
Rtx-5MS capillary column (Thames Restek UK LTD, Windsor, UK) for the presence o f 
triketide lactones. The extract was then loaded onto a column o f silica (14cm diameter x 
14cm length). This was eluted with diethyl ether (400ml), 25% ethyl acetate in diethyl 
ether (400ml), 50% ethyl acetate in diethyl ether (400ml), 75% ethyl acetate in diethyl 
ether (400ml) and ethyl acetate (400ml). The eluent was collected in 8 x 250ml fractions 
that were analysed by GC-MS for the presence o f triketide lactones. The appropriate 
fractions were combined, concentrated to dryness under reduced pressure and dissolved in 
HPLC grade acetonitrile (1.5 ml). To this was added milli-Q water (0.5 ml). The solution 
was filtered through a 0.2 micron filter, ready for preparative HPLC.
A portion o f the semi-pure extract (500pl) was then loaded onto a preparative LC system  
using a reverse phase Prodigy 5p 100Â ODS column (25cm x 2.2cm) (Phenomenex, 
Macclesfield, UK) and eluted using a linear gradient o f 5%-30% acetonitrile over 45 min 
at 20ml/min. The two major peaks corresponding to propionate lactone were collected. The 
LC separation was repeated with a further three aliquots. The appropriate fractions were 
combined, concentrated to dryness under reduced pressure and dissolved in CDClg ready 
for NMR spectroscopic analysis.
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3.4 Synthesis o f standard
Step (a)
(4R)-3-f(2R. 3S)-3-Hvdroxy-2-methylpentanovl1-4-phenvlmethvl-2-QxazQlidinQne (2) 
Dibutylboron triflate (2.6 ml, 12.05mmol, 1.17 eq) and triethylamine (1.648 ml, 
11.84mmol, 1.15eq) were added dropwise to a solution o f (4R)-3-propionyl-4- 
phenylmethyl-2-oxazolidinone (2.4g, 10.30mmol, leq) in dry dichloromethane (80 ml) at 
0°C. This solution was stirred for 1 h, cooled to -78°C and propionaldéhyde (0.816 ml,
11.33mmol, 1.1 eq) was added dropwise. The solution was stirred for Ih at -78°C and then 
for 1.5 h at 0°C. The reaction mixture was quenched by the addition o f pH 7 phosphate 
buffer (16 ml) and methanol (48 ml). A mixture o f methanol-30% aqueous hydrogen 
peroxide (2:1) (43.2 ml) was added dropwise at 0°C and the mixture stirred for 1 h. The 
volatile solvents were carefully removed under reduced pressure and the remaining 
aqueous slurry extracted with dichloromethane (3x80 ml). The combined extracts were 
dried over MgSÛ4, filtered and the solvent was removed under reduced pressure to give the 
crude product. This was purified by flash chromatography eluting with EtOAc : in light 
petroleum (bp 40-60°C) 50 : 50 to give the aldol adduct (2) (2.2g) 74%
[a]D -41.2° ( c 2.6 in CHC13);
Vmax (thin film )/cin1 3487 (OH), 1770 (oxazolidione 0 = 0 ), 1665 (amide C=0); 
ôh(500 MHz; CDCb) 7.36-7.17 (5H, m, Ph), 4.69 (IH, m, 4-H), 4.2 (2H, m, 2x5-H), 3.86 
(IH , m, 3’-H), 3.79 (IH, dq, ^=2.61, 7.0 Hz, 2’H), 3.24 (IH, dd, ^ 1 3 .4 , 3.3 Hz, PhCMÎ), 
2.84 (IH, d, ^=2.7Hz, OH), 2.77 (IH , dd, ^=13.4, 9.5 Hz, PhCHfl), 1.60-1.40 (2H, m, 
2x4’-H), 1.25 (3H, d, ^=7.0Hz, 2’-CH3), 0.97 (3H, d, ^ 7 .4H z, 4 ’-CH3);
(Found: Mf, 291.1474. C10H21NO4 requires M, 291.1471).
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Step(b)
f4RV3-[(2R.3SV3-(ferr-Butvldimethvlsilvloxv-2-methvlpentanovll-4-phenvlmethvl-2-
oxazolidinone (3)
To a solution o f (4R)-3-[(2R,3S)-3-hydroxy-2-methylpentanoyl]-4-phenylmethyl-2- 
oxazolidinone (2.204g, 6.81 mmol, leq) in dry dichloromethane (59.6 ml) at -78°C were 
successively added diisopropylethylamine (2.32 ml, 13.63mmol, 2eq) and tert- 
butyldimethylsilyl triflate (1.638 ml, 7.51 mmol, l.leq ). This solution was stirred until the 
reaction mixture was seen to be complete by t i c  (2h). The volatile materials were then 
removed under reduced pressure and the crude product purified by flash chromatography 
(EtOAc : petroleum ether 3:7 v/v) to afford (3) (2.75g, 84%);
Ôh(500 MHz; CDC13), 7.36-7.17 (5H, m, Ph), 4.69 (IH, m, 4-H), 4.2 (2H, m, 2x5-H), 4.0 
(2H, m, 2’-H, 3’-H), 3.3 (IH, dd, ^=3.2, 13.3Hz, PhC/TH), 2.75 (IH, dd, J=9.7, 13.3Hz, 
PhCHH), 1.60-1.40 (2H, m, 2x4’-H), 1.2 (3H, d, > 6 .7 , 2’-CH3), 0.9 (12H, m, Si-'Bu +4’- 
CH3), 0.11 (3H, s, Si-CH3), 0.09 (3H, s, Si-CH3)
Step (c)
12R. 3 SV3 -/grZ-Butvldimethvlsilvloxv- 2-methvlpentanol (4)
To a solution o f (4R)-3-[(2R, 3S)-3-tert-butyldimethylsilyloxy-2-methylpentanoyl]-4- 
phenylmethyl-2-oxazolidinone (2.75g, 6.8mmol, 1 eq) in diethyl ether (96ml) at 0°C was 
added water (128pl, 7.1 Immol, 1.1 eq) and lithium borohydride (3.64 ml o f 2M solution in 
THF, 7.2mmol, 1.1 eq). This solution was warmed to room temperature and stirred for one 
hour, quenched with 1M sodium hydroxide (64 ml), and stirred for 10 min, then extracted 
with diethyl ether (3x 65 ml). The organic layers were combined, washed with brine (65
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ml), dried over MgSCU and concentrated to dryness under reduced pressure. The crude 
product was purified by flash silica chromatography (EtOAc : petroleum ether 1:4v/v) to 
afford (4) (116mg, 7.4%);
Vmax (thin filmycm'1 3365 (OH)
Step (d)
(2R. 3 Sy3-fert-Butv1dimethv1 silvloxv-2-methvlpentanal (51
:  x
Solid tetrapropylammomum perruthenate (TPAP) (8.78g) was added to a solution o f (2R, 
3 S)-3 -te7t-6utyldimethylsilyloxy-2-methylpentanol (116mg, O.Smmol leq), 4- 
methyImorpholine N-oxide (87.85 mg) and powdered molecular sieves (325 mg) in 
dichloromethane (1 ml ) at room temperature and under argon. This was stirred for Ih 
20min and the crude aldehyde was purified by flash silica chromatography (EtOAc : 
petroleum ether 1:9v/v) to afford (5) (0.065g, 56.5%).
[a]D -21.2° (c 1.10 in CHC13);
Vmax (thin filmycm'1 1727 (C=0);
Ôh(500 MHz; CDC13), 9.67 (IH, d, ^ l.O H z, CHO), 4.02 (IH, td, J=6.6, 3.6Hz, 3^H), 2.45 
(lH,qdd, «7=6.9, 3 .6 ,1.0Hz, 2-H), 1.59-1.45 (2H, m, 2x4-H), 1.04 (3H, d, ^ =6.9Hz, 2-CH3),
0.87 (3H, t, J=7.5Hz, 5-CH3), 0.84 (9H, s, Si-lBu), 0.06 (3H, s, Si-CH3), 0.02 (3H, s, Si- 
CH3);
(Found: [M-H]+, 231.1707. O ^ H ^ S i requires M, 231.1703).
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Step (e1)
f4RV3-[(2R. 3SV3-Hvdroxv-2-methvlpentanovl1-4-phenv1methvl-2-nxa7X)lidinone (9)
Dibutylboron triflate (0.29 ml, 1.34mmol, 1.17eq) and triethylamine (0.19 ml, 1.30mmol,
1.15eq) were added dropwise, successively to a solution o f (4S)-3-propionyl-4- 
phenylmethyl-2-oxazolidinone (8) (0.27 mg, 1.17 mmol, 1 eq) in dry dichloromethane (7 
ml) at 0°C. The solution was stirred for 45 min then cooled to -78°C and (2R, 3S)-3-tert- 
butyldimethylsilyloxy-2-methylpentanal (0.0295 g, 1.28mmol, 1.1 eq) in dry
dichloromethane (3 ml) was added dropwise. The solution was stirred for 30 min at -78°C, 
75 min at 0°C and then 30 min at room temperature. The reaction mixture was then 
quenched by the addition o f pH 7 phosphate buffer (4 ml) and methanol (12 ml). A mixture 
o f methanol-30% aqueous hydrogen peroxide (2:1) (12 ml) was added dropwise at 0°C 
and the cloudy mixture stirred for 1 h. The volatile solvents were removed under reduced 
pressure and the aqueous slurry extracted with dichloromethane (3x20 ml). The extracts 
were combined, washed with brine (40 ml), dried over MgSCU and the solvent was 
removed under reduced pressure. The crude product was purified by flash silica 
chromatography (EtOAc : petroleum ether 15:85 v/v) to afford (9).
Vmax thin filmycm'1 3475 (OH). 1775 (Oxazolidione 0 = 0 ), 1700 (amide 0= 0);
5h(500 MHz; CDC13), 7.34-7.20 (5H, m, Ph), 4.69 (IH, m, 4-H), 4.22-4.08 (2H, m, 2x5- 
H), 4.00 (IH , dd, .7=9.8, 2.0, 2.0Hz, 3’-H), 3.84 (IH , dq, J=6.9, 2.0Hz, 2-H), 3.76 (IH, td, 
J=7.3, 2.5Hz, 5’-H), 3.34 (IH , dd, ^ 1 3 .3 , 3.1Hz, PhCÆH), 2.75 (IH, dd, ^ 1 3 .3 , 9.8JHz; 
PhCHH), 1.82 (IH, dqd, ^=9.8, 7.1, 2.5,Hz, 4’-H), 1.54 (2H, d, ^ 7 .3H z, 2x6’-H), 1.21 
(3H, d, ^=6.9Hz, 2’-CH3), 0.89 (3H, t, ^=7.3Hz, 7'-CH3), 0.88 (9H, s, Si-*Bu), 0.84 (3H, d, 
^=7.1Hz, 4’-CH3), 0.11 (3H, s, Si-CH3), 0.07 (3H, s, Si-CH3)
(Found: M% 463.2760. CisH^NOsSi requires M, 463.2754).
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Step (f)
f2S. 3IL 4R. 5SV3.5-Dihvdroxv-2.4-dimethvl-heptanoic acid-S-lactone (10)
Aqueous hydrogen peroxide (27 wt% in H2O 100 vol, 0.419 ml, 3.3 mmol, 4.5 eq) and 
lithium hydroxide (69.8 mg, 7.7 mmol, 2.25 eq) were added successively to a stirred 
solution o f (4S)-3-[(2S, 3R, 4S, 5,S)-5-^r/-butyldimethylsilyloxy-2,4-dimethyl-3- 
hydroxyheptanyl]-4-phenylmethyl-2-oxazolidinone (344 mg, 0.74mmol, 1 eq) in a mixture 
o f tetrahydrofuran : water (3:1 v/v) (18.6 ml) at 0°C, This was stirred for 30 min at room 
temperature, 75 min at 40°C and cooled to 0°C. It was then quenched with 1.5 M aqueous 
sodium sulfite solution (2.9 ml, 4.36 mmol, 6 eq). The volatile solvents were removed 
under vacuum and the aqueous layer acidified to pH 1 with 1M hydrochloric acid and 
extracted into dichloromethane (3x50 ml). The extracts were combined and concentrated 
under reduced pressure. 1M hydrochloric acid (23.3 ml) and tetrahydrofuran (4.65 ml) 
were added to the oil and the mixture stirred at room temperature for 30 min and 40°C for 
80 min. The volatile solvents were removed under reduced pressure and the aqueous slurry 
extracted with EtOAc (3x50 ml). The extract was washed with brine (70 ml), dried over 
MgSO* and purified by flash silica chromatography (diethyl ether) to give the lactone (10) 
as a white crystalline solid (O.lOIg, 79.4%);
Vmax (Nujol m ull)/cm 1 3450 (OH), 1715 (C =0)
Ôh(500 MHz, CDC13), 4,12(1H, td, .7=6.3, J= 2.3Hz, 5-H), 3.81(1H, dd, ^=10.3, 4.3Hz, 3- 
H), 2.45(1H, dq, ^=10.3, 7.1Hz, 2-H), 2.15(1H, m, 4-H), 1.81(1H, m, Ix6-H), 1.58(1H, m, 
Ix6-H), 1.38(3H, d, ^=7.1Hz, 2-CH3), 0.97(3H, t, ^ 7 .5H z, 7-CH3), 0.93(3H, d, ^=7.1Hz, 
4-CH3);
(Found: M4", 172.1100. C^H^O3 requires Af, 172.1099)
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4.1 Summary and Further Work
Validation o f LCQ and GCQ for quantification o f lactones was carried out. This showed 
that the GCQ calibration curve has good linearity to very low detection limits and may be 
used to accurately quantify triketide lactones.
Optimisation o f HPLC system for isolation o f small quantities o f lactones showed that the 
isolation and handling o f very small quantities o f lactone is possible given the right 
separation conditions.
The method used most for pre-preparative HPLC cleanup was the silica flash column. This 
proved quite effective but was by no means ideal. The use o f size exclusion 
chromatography proved very effective in separating out a large proportion o f the unwanted 
material from the biological extract. The main drawback o f this technique was that 
dichloromethane had to be used to swell the beads so a mixed solvent gradient could not be 
used to draw out peaks. As a result, base-line separation o f peaks was not achieved. If this 
procedure could be optimised it would prove very useful in terms o f sample throughput, as 
the column may be washed and used several times, unlike silica which must be re-packed 
each time.
The successful isolation and characterisation o f two products was achieved. The first 
expected product showed that the DEBS3 area o f the erythromycin PKS acts in a way that 
is expected, even when truncated. The second unexpected product shows not only that KSi 
is capable o f epimerising a chiral centre but that this inversion o f stereochemistry can be 
carried through to modules 5 and 6 where the KR domains accept and reduce them in the 
opposite stereochemical sense. Le. that they can demonstrate relaxed specificity. This is an
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important finding which must be taken into account when designing new polyketide 
synthases.
The fact that one o f the isolated peaks was present in one growth culture and not in another 
seemingly identical pne would indicate that work needs to be carried out surrounding the 
nature in which these organisms grow within the media. Optimisation o f growth media 
would seem an obvious area for investigation, as little is known about exactly how varying 
the relative amounts or types o f electrolytes and nutrients would affect the production o f 
metabolites.
There are, o f course, many other areas o f investigation that would make the isolation and 
identification o f triketide lactones more efficient. These include, among others, automated 
in-line HPLC-NMR and solid phase extraction.
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